Delivery Order SPE2DB22D1106-SPE2DB24FECV7
Award Date 3/3/24
Potential Completion Date 3/4/24
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $28,419.96 and is a delivery order type with a firm fixed price pricing structure. The contract covers the purchase of REMICADE 100 MG VIALS, a pharmaceutical product, with an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $15,472.98, is for the delivery of 4563556914 REMICADE 100 MG VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 6, 2024. The contract was awarded on February 5, 2024 and was not set aside for a specific business type. Amerisourcebergen Drug Corp is a major...
- This federal contract award, with an ID of SPE2DX15D1022|SPE2DX23FVBDZ, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,318.47 firm fixed-price delivery order is for the supply of 4559368349 REMICADE 100 MG VIALS to support the government's medical requirements. This contract is not set aside and has an ultimate completion date of December 14, 2022. Amerisourcebergen Drug Corp, a major...
- This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUG84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.10 firm fixed-price delivery order contract is for the supply of 4567038437 REMICADE 100 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant...
- This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FDPD5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,140.58 delivery order is for the provision of 4562983414 REMICADE 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 5, 2023. The contract was awarded on December 4, 2022 and was not set aside for any specific business type....
- This federal contract award, valued at $14,536.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566598452 REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FAJQ7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of REMICADE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $3,055.35 and a period of performance ending on January 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FY63C, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,525.37 Firm Fixed Price Delivery Order contract is for the supply of REMICADE 100 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. It is not designated as a set-aside contract....
- This federal contract award, valued at $19,112.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of REMICADE 100 MG VIALS. The award is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has a completion date of May 31, 2024 and was awarded on May 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- This federal contract award, with ID SPE2DB22D1202|SPE2DB24FVCA5, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,469.60 delivery order contract is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of June 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...